At the news
? BEARISHIMPACT 6/10 424B5 filed Jul 30, 2026 at 17:27 ET
Inovio Pharmaceuticals (INO) is raising ~$18.3M net via a 424B5 takedown from its $300M shelf, selling 21.1M shares and warrants for 42.1M shares at $0.95/unit (a ~8% discount to the $1.03 close). The company also disclosed a going-concern risk, preliminary cash of $36.7M as of June 30, 2026, and that the FDA has not yet ruled on INO-3107's accelerated approval eligibility ahead of the October 30 PDUFA date. This offering adds ~30% immediate dilution from shares alone, with potential for further dilution from the 2:1 warrant coverage.
- Offering of 21,052,632 shares and warrants for 42,105,264 shares at $0.95/unit, raising ~$18.3M net ($20M gross)
- Warrants exercisable at $1.10/share for 5 years; no public market expected for warrants
- Pro forma as-adjusted net tangible book value per share of $0.58 vs. offering price of $0.95 = $0.37 immediate dilution per share
- Company discloses 'substantial doubt exists as to our ability to continue as a going concern'
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access